Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma
Siddharth J. Modi, Vithal M. Kulkarni
Topics & Concepts
CD44Epithelial–mesenchymal transitionCancer researchCancer stem cellVimentinChemistryMetastasisMesenchymal stem cellHepatocellular carcinomaCancerVascular endothelial growth factorCellBiologyImmunologyInternal medicineMedicineCell biologyImmunohistochemistryVEGF receptorsBiochemistryCancer Cells and MetastasisAngiogenesis and VEGF in CancerCancer, Hypoxia, and Metabolism